hrp0089p1-p133 | Fat, Metabolism and Obesity P1 | ESPE2018

Severe Obesity and Cardiometabolic Comorbidities in Adolescents: Chronology of an Epidemic

Pinhas-Hamiel Orit , Reichman Brian , Afek Arnon , Derazne Estela , Hamiel Uri , Furer Ariel , Gershovitz Liron , Kark Jeremy D , Bader Tarif , Twig Gilad

Aims: To assess trend in the prevalence of severe obesity in a national population-based sample of adolescents and to evaluate the association of severe obesity with major cardio-metabolic morbidities.Methods: Prevalence and severity of obesity was determined among 373,226 Israeli adolescents with abnormal BMI (≥85th percentile for age and sex) examined in an obligatory health assessment at mean age 17.3±0.5 years between 1967 and 2...

hrp0097p1-492 | GH and IGFs | ESPE2023

GH stimulation testing: is it time to change the paradigm?

Smuel Keren , Lazar Liora , Yackobovitch-Gavan Michal , Tirosh Liron , Phillip Moshe , Oron Tal , Sarah Flanagan , Jayne Houghton

Background: The efficacy of growth hormone (GH) treatment in short, healthy children diagnosed with growth hormone deficiency (GHD) or those meeting the criteria of idiopathic short stature (ISS) suggest that an overlap exists between these two conditions. Although flawed and inconsistent, growth hormone stimulation tests (GHST) are the key diagnostic tool differentiating between GHD and ISS affecting clinical decisions such as treatment eligibility and dose.<...